Jubilant Life Sciences presents 1,000 vials of Remdesivir to UP CM

The drug is being made available to over 1,000 hospitals providing Covid-19 treatment in India through the company's distribution network

remdesivir, coronavirus, drugs, covid, pharma
The company is donating 1000 vials of JUBI-R through its CSR arm, the Jubilant Bhartia Foundation, he added.
Press Trust of India Noida
1 min read Last Updated : Aug 08 2020 | 7:59 PM IST
Drug firm Jubilant Life Sciences on Saturday said it has presented 1,000 vials of antiviral drug Remdesivir that it sells under the brand name 'JUBI-R' to Uttar Pradesh Chief Minister Yogi Adityanath.

The drug is being made available to over 1,000 hospitals providing Covid-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement.

"Remdesivir is an effective medicine in the treatment of severe Covid-19 cases. In this critical situation, I am pleased that this medicine was made available by Jubilant in the quick time of two and a half months," the company quoted Adityanath as saying.
"It gives us immense pleasure and satisfaction to present JUBI-R', the life-saving medicine, to Chief Minister of Uttar Pradesh Yogi Adityanath," Jubilant Life Sciences Chairman Shyam S Bhartia said.

The company is donating 1000 vials of JUBI-R through its CSR arm, the Jubilant Bhartia Foundation, he added.

In May 2020, Jubilant entered into a non-exclusive licensing agreement with Gilead Sciences, Inc., that granted it the right to register, manufacture and sell Gilead's investigational drug remdesivir in 127 countries including India, the company said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusJubilant Life SciencesYogi Adityanath

Next Story